Published in Urology on April 01, 2002
gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci U S A (2004) 1.52
Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers. J Nutr (2011) 0.98
Genetic polymorphisms and prostate cancer risk. World J Urol (2003) 0.96
Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status. Mol Med (2010) 0.94
Nutraceuticals in Prostate Disease: The Urologist's Role. Rev Urol (2008) 0.83
Methaneseleninic acid and γ-Tocopherol combination inhibits prostate tumor growth in Vivo in a xenograft mouse model. Oncotarget (2014) 0.80
A review of phase III clinical trials of prostate cancer chemoprevention. Ann R Coll Surg Engl (2007) 0.79
Cytotoxicity of liposomal alpha-tocopheryl succinate towards hamster cheek pouch carcinoma (HCPC-1) cells in culture. Cancer Lett (2005) 0.75
Short-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trial. Res Rep Urol (2014) 0.75
Chemoprevention and prostate cancer. Rev Urol (2003) 0.75
Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective. Urology (2002) 0.79
Dietary fat reduction to reduce prostate cancer risk: controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture. Urology (2002) 0.79
Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations. Adv Ther (2008) 0.77
Educating patients about lifestyle modifications for prostate health. Am J Med (2008) 0.77
Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part I. Curr Opin Urol (2005) 0.75
Mind-body effect: insulinlike growth factor-1; clinical depression; and breast, prostate, and other cancer risk-an unmeasured and masked mediator of potential significance? Urology (2002) 0.75
Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part II. Curr Opin Urol (2005) 0.75